ReP USP - Resultado da busca

Artigo de periodico
Serum levels of IgG antibodies against oxidized LDL and atherogenic indices in HIV-1-infected patients treated with protease inhibitors (2013)
Cunha, Joel da; Maselli, Luciana Morganti Ferreira; Treitinger, Arício; Monteiro, Andrea Moreira; Gidlund, Magnus Ake ; Maranhão, Raul Cavalcante ; Spada, Celso; Bydlowski, Sérgio Paulo
Fonte: Clinical Chemistry and Laboratory Medicine. Unidades: ICB, FCF, FM
Assuntos: LIPOPROTEÍNAS LDL, HIV
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CUNHA, Joel da et al. Serum levels of IgG antibodies against oxidized LDL and atherogenic indices in HIV-1-infected patients treated with protease inhibitors. Clinical Chemistry and Laboratory Medicine, v. 51, n. 2, p. 371-378, 2013Tradução . . Disponível em: https://doi.org/10.1515/cclm-2012-0225. Acesso em: 26 out. 2025.
APA
Cunha, J. da, Maselli, L. M. F., Treitinger, A., Monteiro, A. M., Gidlund, M. A., Maranhão, R. C., et al. (2013). Serum levels of IgG antibodies against oxidized LDL and atherogenic indices in HIV-1-infected patients treated with protease inhibitors. Clinical Chemistry and Laboratory Medicine, 51( 2), 371-378. doi:10.1515/cclm-2012-0225
NLM
Cunha J da, Maselli LMF, Treitinger A, Monteiro AM, Gidlund MA, Maranhão RC, Spada C, Bydlowski SP. Serum levels of IgG antibodies against oxidized LDL and atherogenic indices in HIV-1-infected patients treated with protease inhibitors [Internet]. Clinical Chemistry and Laboratory Medicine. 2013 ; 51( 2): 371-378.[citado 2025 out. 26 ] Available from: https://doi.org/10.1515/cclm-2012-0225
Vancouver
Cunha J da, Maselli LMF, Treitinger A, Monteiro AM, Gidlund MA, Maranhão RC, Spada C, Bydlowski SP. Serum levels of IgG antibodies against oxidized LDL and atherogenic indices in HIV-1-infected patients treated with protease inhibitors [Internet]. Clinical Chemistry and Laboratory Medicine. 2013 ; 51( 2): 371-378.[citado 2025 out. 26 ] Available from: https://doi.org/10.1515/cclm-2012-0225
Artigo de periodico
Uric acid biorhythm, a feature of long-term variation in a clinical laboratory database (2012)
Andrade, Mauricio Pacheco de; Hirata, Rosario Dominguez Crespo ; Sandrini, Fabiano; Largura, Alvaro; Hirata, Mario Hiroyuki
Fonte: Clinical Chemistry and Laboratory Medicine. Unidade: FCF
Assuntos: ÁCIDO ÚRICO, BANCO DE DADOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDRADE, Mauricio Pacheco de et al. Uric acid biorhythm, a feature of long-term variation in a clinical laboratory database. Clinical Chemistry and Laboratory Medicine, v. 50, n. 5, p. 853-859, 2012Tradução . . Disponível em: https://doi.org/10.1515/cclm-2011-0150. Acesso em: 26 out. 2025.
APA
Andrade, M. P. de, Hirata, R. D. C., Sandrini, F., Largura, A., & Hirata, M. H. (2012). Uric acid biorhythm, a feature of long-term variation in a clinical laboratory database. Clinical Chemistry and Laboratory Medicine, 50( 5), 853-859. doi:10.1515/cclm-2011-0150
NLM
Andrade MP de, Hirata RDC, Sandrini F, Largura A, Hirata MH. Uric acid biorhythm, a feature of long-term variation in a clinical laboratory database [Internet]. Clinical Chemistry and Laboratory Medicine. 2012 ; 50( 5): 853-859.[citado 2025 out. 26 ] Available from: https://doi.org/10.1515/cclm-2011-0150
Vancouver
Andrade MP de, Hirata RDC, Sandrini F, Largura A, Hirata MH. Uric acid biorhythm, a feature of long-term variation in a clinical laboratory database [Internet]. Clinical Chemistry and Laboratory Medicine. 2012 ; 50( 5): 853-859.[citado 2025 out. 26 ] Available from: https://doi.org/10.1515/cclm-2011-0150
Artigo de periodico
Genotyping of the hemochromatosis HFE p.H63D and p.C282Y mutations by high-resolution melting with the Rotor-Gene 6000(®) instrument (2011)
Santos, Paulo Caleb Junior de Lima; Soares, Renata Alonso Gadi; Krieger, José Eduardo; Guerra-Shinohara, Elvira Maria ; Pereira, Alexandre Costa
Fonte: Clinical Chemistry and Laboratory Medicine. Unidades: FM, FCF
Assuntos: HEMOCROMATOSE, GENÓTIPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Paulo Caleb Junior de Lima et al. Genotyping of the hemochromatosis HFE p.H63D and p.C282Y mutations by high-resolution melting with the Rotor-Gene 6000(®) instrument. Clinical Chemistry and Laboratory Medicine, v. 49, n. 10, p. 1633-1636, 2011Tradução . . Disponível em: https://doi.org/10.1515/cclm.2011.654. Acesso em: 26 out. 2025.
APA
Santos, P. C. J. de L., Soares, R. A. G., Krieger, J. E., Guerra-Shinohara, E. M., & Pereira, A. C. (2011). Genotyping of the hemochromatosis HFE p.H63D and p.C282Y mutations by high-resolution melting with the Rotor-Gene 6000(®) instrument. Clinical Chemistry and Laboratory Medicine, 49( 10), 1633-1636. doi:10.1515/cclm.2011.654
NLM
Santos PCJ de L, Soares RAG, Krieger JE, Guerra-Shinohara EM, Pereira AC. Genotyping of the hemochromatosis HFE p.H63D and p.C282Y mutations by high-resolution melting with the Rotor-Gene 6000(®) instrument [Internet]. Clinical Chemistry and Laboratory Medicine. 2011 ; 49( 10): 1633-1636.[citado 2025 out. 26 ] Available from: https://doi.org/10.1515/cclm.2011.654
Vancouver
Santos PCJ de L, Soares RAG, Krieger JE, Guerra-Shinohara EM, Pereira AC. Genotyping of the hemochromatosis HFE p.H63D and p.C282Y mutations by high-resolution melting with the Rotor-Gene 6000(®) instrument [Internet]. Clinical Chemistry and Laboratory Medicine. 2011 ; 49( 10): 1633-1636.[citado 2025 out. 26 ] Available from: https://doi.org/10.1515/cclm.2011.654
Trabalho de evento-resumo periodico
Effects of pioglitazone on PPARG, TNFA and osteoprotegerin expression in leukocytes and bone turnover biomarkers in diabetic individuals (2010)
Himelfarb, Silvia Tchernin; Silva, F. A; Arazi, Simone Sorkin; Farjado, C. M; Oliveira, Raquel; Bertolami, Marcelo Chiara; Rezende, A. A; Bertolami, A; Faludi, A; Sampaio, M. F; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Fonte: Clinical Chemistry and Laboratory Medicine. Nome do evento: Santorini Conference Biologie Prospective. Unidade: FCF
Assuntos: DIABETES MELLITUS, BIOMARCADORES, LEUCÓCITOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HIMELFARB, Silvia Tchernin et al. Effects of pioglitazone on PPARG, TNFA and osteoprotegerin expression in leukocytes and bone turnover biomarkers in diabetic individuals. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 26 out. 2025. , 2010
APA
Himelfarb, S. T., Silva, F. A., Arazi, S. S., Farjado, C. M., Oliveira, R., Bertolami, M. C., et al. (2010). Effects of pioglitazone on PPARG, TNFA and osteoprotegerin expression in leukocytes and bone turnover biomarkers in diabetic individuals. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Himelfarb ST, Silva FA, Arazi SS, Farjado CM, Oliveira R, Bertolami MC, Rezende AA, Bertolami A, Faludi A, Sampaio MF, Hirata RDC, Hirata MH. Effects of pioglitazone on PPARG, TNFA and osteoprotegerin expression in leukocytes and bone turnover biomarkers in diabetic individuals. Clinical Chemistry and Laboratory Medicine. 2010 ; 48( 8): A67 res. B12.[citado 2025 out. 26 ]
Vancouver
Himelfarb ST, Silva FA, Arazi SS, Farjado CM, Oliveira R, Bertolami MC, Rezende AA, Bertolami A, Faludi A, Sampaio MF, Hirata RDC, Hirata MH. Effects of pioglitazone on PPARG, TNFA and osteoprotegerin expression in leukocytes and bone turnover biomarkers in diabetic individuals. Clinical Chemistry and Laboratory Medicine. 2010 ; 48( 8): A67 res. B12.[citado 2025 out. 26 ]
Trabalho de evento-resumo periodico
Effects of lipid-lowering drugs on reverse cholesterol transport gene expressions in Caco-2 cells (2010)
Genvigir, Fabiana Dalla Vecchia; Rodrigues, Alice Cristina ; Hirata, Mario Hiroyuki ; Curi, Rui; Hirata, Rosario Dominguez Crespo
Fonte: Clinical Chemistry and Laboratory Medicine. Nome do evento: Santorini Conference Biologie Prospective. Unidades: FCF, ICB
Assuntos: EXPRESSÃO GÊNICA, COLESTEROL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GENVIGIR, Fabiana Dalla Vecchia et al. Effects of lipid-lowering drugs on reverse cholesterol transport gene expressions in Caco-2 cells. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 26 out. 2025. , 2010
APA
Genvigir, F. D. V., Rodrigues, A. C., Hirata, M. H., Curi, R., & Hirata, R. D. C. (2010). Effects of lipid-lowering drugs on reverse cholesterol transport gene expressions in Caco-2 cells. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Genvigir FDV, Rodrigues AC, Hirata MH, Curi R, Hirata RDC. Effects of lipid-lowering drugs on reverse cholesterol transport gene expressions in Caco-2 cells. Clinical Chemistry and Laboratory Medicine. 2010 ; 48( 8): A66 res. B11.[citado 2025 out. 26 ]
Vancouver
Genvigir FDV, Rodrigues AC, Hirata MH, Curi R, Hirata RDC. Effects of lipid-lowering drugs on reverse cholesterol transport gene expressions in Caco-2 cells. Clinical Chemistry and Laboratory Medicine. 2010 ; 48( 8): A66 res. B11.[citado 2025 out. 26 ]
Trabalho de evento-resumo periodico
Clopidogrel response is affected by ABCC3 expression but not ABCB1 in CAD patients (2010)
Luchessi, André Ducati; Silbiger, Vivian Nogueira; Hirata, Rosario Dominguez Crespo ; Cerda, Alvaro; Carracedo, A; Brion, Marcel; Iñigues, A; Bravo, M. S; Bastos, G; Sousa, A. G. M. R; Hirata, Mario Hiroyuki
Fonte: Clinical Chemistry and Laboratory Medicine. Nome do evento: Santorini Conference Biologie Prospective. Unidade: FCF
Assunto: EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LUCHESSI, André Ducati et al. Clopidogrel response is affected by ABCC3 expression but not ABCB1 in CAD patients. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 26 out. 2025. , 2010
APA
Luchessi, A. D., Silbiger, V. N., Hirata, R. D. C., Cerda, A., Carracedo, A., Brion, M., et al. (2010). Clopidogrel response is affected by ABCC3 expression but not ABCB1 in CAD patients. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Luchessi AD, Silbiger VN, Hirata RDC, Cerda A, Carracedo A, Brion M, Iñigues A, Bravo MS, Bastos G, Sousa AGMR, Hirata MH. Clopidogrel response is affected by ABCC3 expression but not ABCB1 in CAD patients. Clinical Chemistry and Laboratory Medicine. 2010 ; 48( 8): A69 res. B19.[citado 2025 out. 26 ]
Vancouver
Luchessi AD, Silbiger VN, Hirata RDC, Cerda A, Carracedo A, Brion M, Iñigues A, Bravo MS, Bastos G, Sousa AGMR, Hirata MH. Clopidogrel response is affected by ABCC3 expression but not ABCB1 in CAD patients. Clinical Chemistry and Laboratory Medicine. 2010 ; 48( 8): A69 res. B19.[citado 2025 out. 26 ]
Trabalho de evento-resumo periodico
Polymorphism of the gene of Lep, LEPR, AdipoQ and IL-6 and possible involvement in obesity and diabetes mellitus in Brazilian population (2010)
Oliveira, Raquel; Genvigir, Fabiana Dalla Vecchia; Cerda, Alvaro; Dórea, Egidio Lima; Bernik, Marcia Martins Silveira; Jorge, M. E. I; Fajardo, Cristina Moreno ; Crema, Daniela; Machado, J. E. A; Martinez, M. B; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Fonte: Clinical Chemistry and Laboratory Medicine. Nome do evento: Santorini Conference Biologie Prospective. Unidades: HU, FCF
Assuntos: POLIMORFISMO, DIABETES MELLITUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Raquel et al. Polymorphism of the gene of Lep, LEPR, AdipoQ and IL-6 and possible involvement in obesity and diabetes mellitus in Brazilian population. Clinical Chemistry and Laboratory Medicine. Berlin: Hospital Universitário, Universidade de São Paulo. . Acesso em: 26 out. 2025. , 2010
APA
Oliveira, R., Genvigir, F. D. V., Cerda, A., Dórea, E. L., Bernik, M. M. S., Jorge, M. E. I., et al. (2010). Polymorphism of the gene of Lep, LEPR, AdipoQ and IL-6 and possible involvement in obesity and diabetes mellitus in Brazilian population. Clinical Chemistry and Laboratory Medicine. Berlin: Hospital Universitário, Universidade de São Paulo.
NLM
Oliveira R, Genvigir FDV, Cerda A, Dórea EL, Bernik MMS, Jorge MEI, Fajardo CM, Crema D, Machado JEA, Martinez MB, Hirata MH, Hirata RDC. Polymorphism of the gene of Lep, LEPR, AdipoQ and IL-6 and possible involvement in obesity and diabetes mellitus in Brazilian population. Clinical Chemistry and Laboratory Medicine. 2010 ; 48( 8): A56-A56 res. A24.[citado 2025 out. 26 ]
Vancouver
Oliveira R, Genvigir FDV, Cerda A, Dórea EL, Bernik MMS, Jorge MEI, Fajardo CM, Crema D, Machado JEA, Martinez MB, Hirata MH, Hirata RDC. Polymorphism of the gene of Lep, LEPR, AdipoQ and IL-6 and possible involvement in obesity and diabetes mellitus in Brazilian population. Clinical Chemistry and Laboratory Medicine. 2010 ; 48( 8): A56-A56 res. A24.[citado 2025 out. 26 ]
Trabalho de evento-resumo periodico
Atorvastatin down-regulates APOE mRNA expression in postmenopausal women (2010)
Issa, Mustafa Hassan; Cerda, Alvaro; Genvigir, Fabiana Dalla Vecchia; Cavalli, Selma Andrea; Bertolami, Marcelo Chiara; Faludi, André Arpad; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Fonte: Clinical Chemistry and Laboratory Medicine. Nome do evento: Santorini Conference Biologie Prospective. Unidade: FCF
Assuntos: PÓS-MENOPAUSA, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ISSA, Mustafa Hassan et al. Atorvastatin down-regulates APOE mRNA expression in postmenopausal women. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 26 out. 2025. , 2010
APA
Issa, M. H., Cerda, A., Genvigir, F. D. V., Cavalli, S. A., Bertolami, M. C., Faludi, A. A., et al. (2010). Atorvastatin down-regulates APOE mRNA expression in postmenopausal women. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Issa MH, Cerda A, Genvigir FDV, Cavalli SA, Bertolami MC, Faludi AA, Hirata MH, Hirata RDC. Atorvastatin down-regulates APOE mRNA expression in postmenopausal women. Clinical Chemistry and Laboratory Medicine. 2010 ; 48( 8): A68 res. B15.[citado 2025 out. 26 ]
Vancouver
Issa MH, Cerda A, Genvigir FDV, Cavalli SA, Bertolami MC, Faludi AA, Hirata MH, Hirata RDC. Atorvastatin down-regulates APOE mRNA expression in postmenopausal women. Clinical Chemistry and Laboratory Medicine. 2010 ; 48( 8): A68 res. B15.[citado 2025 out. 26 ]
Trabalho de evento-resumo periodico
Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression (2010)
Cerda, Alvaro; Genvigir, Fabiana Dalla Vecchia; Rodrigues, Alice Cristina ; Arazi, Simone Sorkin; Oliveira, Raquel; Dórea, Egidio Lima; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Fonte: Clinical Chemistry and Laboratory Medicine. Nome do evento: Santorini Conference Biologie Prospective. Unidades: HU, FCF
Assuntos: POLIMORFISMO, COLESTEROL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERDA, Alvaro et al. Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression. Clinical Chemistry and Laboratory Medicine. Berlin: Hospital Universitário, Universidade de São Paulo. . Acesso em: 26 out. 2025. , 2010
APA
Cerda, A., Genvigir, F. D. V., Rodrigues, A. C., Arazi, S. S., Oliveira, R., Dórea, E. L., et al. (2010). Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression. Clinical Chemistry and Laboratory Medicine. Berlin: Hospital Universitário, Universidade de São Paulo.
NLM
Cerda A, Genvigir FDV, Rodrigues AC, Arazi SS, Oliveira R, Dórea EL, Hirata MH, Hirata RDC. Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression. Clinical Chemistry and Laboratory Medicine. 2010 ; 48( 8): A64-A64 res. B4.[citado 2025 out. 26 ]
Vancouver
Cerda A, Genvigir FDV, Rodrigues AC, Arazi SS, Oliveira R, Dórea EL, Hirata MH, Hirata RDC. Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression. Clinical Chemistry and Laboratory Medicine. 2010 ; 48( 8): A64-A64 res. B4.[citado 2025 out. 26 ]
Artigo de periodico-carta/editorial
Positive correlations between serum and plasma matrix metalloproteinase (MMP)-2 or MMP-9 levels in disease conditions. [Carta] (2009)
Gerlach, Raquel F.; Meschiari, Cesar A.; Marcaccini, Andrea M.; Palei, Ana C. T.; Sandrim, Valeria C.; Cavalli, Ricardo C.; Santos, José Eduardo Tanus dos
Fonte: Clinical Chemistry and Laboratory Medicine. Unidades: FORP, FMRP
Assuntos: METALOPROTEINASES, PLASMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GERLACH, Raquel F. et al. Positive correlations between serum and plasma matrix metalloproteinase (MMP)-2 or MMP-9 levels in disease conditions. [Carta]. Clinical Chemistry and Laboratory Medicine. Berlim: Faculdade de Odontologia de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 26 out. 2025. , 2009
APA
Gerlach, R. F., Meschiari, C. A., Marcaccini, A. M., Palei, A. C. T., Sandrim, V. C., Cavalli, R. C., & Santos, J. E. T. dos. (2009). Positive correlations between serum and plasma matrix metalloproteinase (MMP)-2 or MMP-9 levels in disease conditions. [Carta]. Clinical Chemistry and Laboratory Medicine. Berlim: Faculdade de Odontologia de Ribeirão Preto, Universidade de São Paulo.
NLM
Gerlach RF, Meschiari CA, Marcaccini AM, Palei ACT, Sandrim VC, Cavalli RC, Santos JET dos. Positive correlations between serum and plasma matrix metalloproteinase (MMP)-2 or MMP-9 levels in disease conditions. [Carta]. Clinical Chemistry and Laboratory Medicine. 2009 ; 47( 7):[citado 2025 out. 26 ]
Vancouver
Gerlach RF, Meschiari CA, Marcaccini AM, Palei ACT, Sandrim VC, Cavalli RC, Santos JET dos. Positive correlations between serum and plasma matrix metalloproteinase (MMP)-2 or MMP-9 levels in disease conditions. [Carta]. Clinical Chemistry and Laboratory Medicine. 2009 ; 47( 7):[citado 2025 out. 26 ]
Trabalho de evento-resumo periodico
Renal alterations in children with type 1 diabetes: association to metabolic control and socioeconomic status (2008)
Oliveira, G. H. M.; Loureiro, M. B.; Ururahy, Marcela Abbott Galvão; Brito, Tereza Neuma de Souza; Hirata, Mario Hiroyuki ; Arrais, Ricardo Fernando; Almeida, M. G.; Rezende, Adriana Augusto de
Fonte: Clinical Chemistry and Laboratory Medicine. Nome do evento: International Congress of Clinical Chemistry and Laboratory Medicine/IFCC-WorldLab. Unidade: FCF
Assuntos: DIABETES MELLITUS INSULINO-DEPENDENTE, NEFROPATIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, G. H. M. et al. Renal alterations in children with type 1 diabetes: association to metabolic control and socioeconomic status. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 26 out. 2025. , 2008
APA
Oliveira, G. H. M., Loureiro, M. B., Ururahy, M. A. G., Brito, T. N. de S., Hirata, M. H., Arrais, R. F., et al. (2008). Renal alterations in children with type 1 diabetes: association to metabolic control and socioeconomic status. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Oliveira GHM, Loureiro MB, Ururahy MAG, Brito TN de S, Hirata MH, Arrais RF, Almeida MG, Rezende AA de. Renal alterations in children with type 1 diabetes: association to metabolic control and socioeconomic status. Clinical Chemistry and Laboratory Medicine. 2008 ; 46 ( S1): S191 res. M026.[citado 2025 out. 26 ]
Vancouver
Oliveira GHM, Loureiro MB, Ururahy MAG, Brito TN de S, Hirata MH, Arrais RF, Almeida MG, Rezende AA de. Renal alterations in children with type 1 diabetes: association to metabolic control and socioeconomic status. Clinical Chemistry and Laboratory Medicine. 2008 ; 46 ( S1): S191 res. M026.[citado 2025 out. 26 ]
Trabalho de evento-resumo periodico
Scavenger receptor class B type I polymorphisms and its relation with serum lipids profile and response to atorvastatin in Brazilian individuals (2008)
Cerda, Alvaro; Arazi, Simone Sorkin; Genvigir, Fabiana Dalla Vecchia; Hirata, Mario Hiroyuki ; Dórea, Egidio Lima; Bernik, Marcia Martins Silveira; Hirata, Rosario Dominguez Crespo
Fonte: Clinical Chemistry and Laboratory Medicine. Nome do evento: International Congress of Clinical Chemistry and Laboratory Medicine/IFCC-WorldLab. Unidades: FCF, HU
Assuntos: POLIMORFISMO, FARMACOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERDA, Alvaro et al. Scavenger receptor class B type I polymorphisms and its relation with serum lipids profile and response to atorvastatin in Brazilian individuals. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 26 out. 2025. , 2008
APA
Cerda, A., Arazi, S. S., Genvigir, F. D. V., Hirata, M. H., Dórea, E. L., Bernik, M. M. S., & Hirata, R. D. C. (2008). Scavenger receptor class B type I polymorphisms and its relation with serum lipids profile and response to atorvastatin in Brazilian individuals. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Cerda A, Arazi SS, Genvigir FDV, Hirata MH, Dórea EL, Bernik MMS, Hirata RDC. Scavenger receptor class B type I polymorphisms and its relation with serum lipids profile and response to atorvastatin in Brazilian individuals. Clinical Chemistry and Laboratory Medicine. 2008 ; 46 ( S1): S571 res. W202.[citado 2025 out. 26 ]
Vancouver
Cerda A, Arazi SS, Genvigir FDV, Hirata MH, Dórea EL, Bernik MMS, Hirata RDC. Scavenger receptor class B type I polymorphisms and its relation with serum lipids profile and response to atorvastatin in Brazilian individuals. Clinical Chemistry and Laboratory Medicine. 2008 ; 46 ( S1): S571 res. W202.[citado 2025 out. 26 ]
Trabalho de evento-resumo periodico
A proposed data structure for application in investigation of analytical processes in clinical laboratories (2008)
Andrade, Mauricio Pacheco de; Darolt, Nelson J.; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Fonte: Clinical Chemistry and Laboratory Medicine. Nome do evento: International Congress of Clinical Chemistry and Laboratory Medicine/IFCC-WorldLab. Unidade: FCF
Assuntos: CONTROLE DA QUALIDADE, CRONOBIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDRADE, Mauricio Pacheco de et al. A proposed data structure for application in investigation of analytical processes in clinical laboratories. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 26 out. 2025. , 2008
APA
Andrade, M. P. de, Darolt, N. J., Hirata, R. D. C., & Hirata, M. H. (2008). A proposed data structure for application in investigation of analytical processes in clinical laboratories. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Andrade MP de, Darolt NJ, Hirata RDC, Hirata MH. A proposed data structure for application in investigation of analytical processes in clinical laboratories. Clinical Chemistry and Laboratory Medicine. 2008 ; 46 ( S1): S430 res. T094.[citado 2025 out. 26 ]
Vancouver
Andrade MP de, Darolt NJ, Hirata RDC, Hirata MH. A proposed data structure for application in investigation of analytical processes in clinical laboratories. Clinical Chemistry and Laboratory Medicine. 2008 ; 46 ( S1): S430 res. T094.[citado 2025 out. 26 ]
Artigo de periodico
Validation of a novel ELISA for measurement of electronegative low-density lipoprotein (2008)
Faulin, Tanize do Espírito Santo; Sena, Karine Cavalcanti Maurício de; Telles, Andréia Elisa Rodrigues; Grosso, Daniela de Mattos; Faulin, Edson José Bernardi; Abdalla, Dulcinéia Saes Parra
Fonte: Clinical Chemistry and Laboratory Medicine. Unidade: FCF
Assuntos: ARTERIOSCLEROSE, IMUNOENSAIO, LIPOPROTEÍNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FAULIN, Tanize do Espírito Santo et al. Validation of a novel ELISA for measurement of electronegative low-density lipoprotein. Clinical Chemistry and Laboratory Medicine, v. 46, n. 12, p. 1769-1775, 2008Tradução . . Disponível em: https://doi.org/10.1515/CCLM.2008.333. Acesso em: 26 out. 2025.
APA
Faulin, T. do E. S., Sena, K. C. M. de, Telles, A. E. R., Grosso, D. de M., Faulin, E. J. B., & Abdalla, D. S. P. (2008). Validation of a novel ELISA for measurement of electronegative low-density lipoprotein. Clinical Chemistry and Laboratory Medicine, 46( 12), 1769-1775. doi:10.1515/CCLM.2008.333
NLM
Faulin T do ES, Sena KCM de, Telles AER, Grosso D de M, Faulin EJB, Abdalla DSP. Validation of a novel ELISA for measurement of electronegative low-density lipoprotein [Internet]. Clinical Chemistry and Laboratory Medicine. 2008 ; 46( 12): 1769-1775.[citado 2025 out. 26 ] Available from: https://doi.org/10.1515/CCLM.2008.333
Vancouver
Faulin T do ES, Sena KCM de, Telles AER, Grosso D de M, Faulin EJB, Abdalla DSP. Validation of a novel ELISA for measurement of electronegative low-density lipoprotein [Internet]. Clinical Chemistry and Laboratory Medicine. 2008 ; 46( 12): 1769-1775.[citado 2025 out. 26 ] Available from: https://doi.org/10.1515/CCLM.2008.333
Trabalho de evento-resumo periodico
mRA expression of SREBF1 and NPC1L1 genes in peripheral blood and mononuclear cells is modulated by simvastatin combined with ezetimibe therapy (2008)
Arazi, Simone Sorkin; Genvigir, Fabiana Dalla Vecchia; Willrich, Maria Alice Vieira; Hirata, Mario Hiroyuki ; Nakandakare, Edna Regina; Neves, M. S. T.; Hirata, Rosario Dominguez Crespo
Fonte: Clinical Chemistry and Laboratory Medicine. Nome do evento: International Congress of Clinical Chemistry and Laboratory Medicine/IFCC-WorldLab. Unidade: FCF
Assuntos: EXPRESSÃO GÊNICA, FARMACOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARAZI, Simone Sorkin et al. mRA expression of SREBF1 and NPC1L1 genes in peripheral blood and mononuclear cells is modulated by simvastatin combined with ezetimibe therapy. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 26 out. 2025. , 2008
APA
Arazi, S. S., Genvigir, F. D. V., Willrich, M. A. V., Hirata, M. H., Nakandakare, E. R., Neves, M. S. T., & Hirata, R. D. C. (2008). mRA expression of SREBF1 and NPC1L1 genes in peripheral blood and mononuclear cells is modulated by simvastatin combined with ezetimibe therapy. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Arazi SS, Genvigir FDV, Willrich MAV, Hirata MH, Nakandakare ER, Neves MST, Hirata RDC. mRA expression of SREBF1 and NPC1L1 genes in peripheral blood and mononuclear cells is modulated by simvastatin combined with ezetimibe therapy. Clinical Chemistry and Laboratory Medicine. 2008 ; 46 ( S1): S570 res. W070.[citado 2025 out. 26 ]
Vancouver
Arazi SS, Genvigir FDV, Willrich MAV, Hirata MH, Nakandakare ER, Neves MST, Hirata RDC. mRA expression of SREBF1 and NPC1L1 genes in peripheral blood and mononuclear cells is modulated by simvastatin combined with ezetimibe therapy. Clinical Chemistry and Laboratory Medicine. 2008 ; 46 ( S1): S570 res. W070.[citado 2025 out. 26 ]
Artigo de periodico
Functional polymorphisms in the promoter of the matrix metalloproteinase-9 (MMP-9) gene are not linked with significant plasma MMP-9 variations in healthy subjects (2008)
Demacq, Caroline; Vasconcellos, Vivian B.; Marcaccini, Andrea M.; Gerlach, Raquel Fernanda; Silva Júnior, Wilson Araújo da; Tanus-Santos, José Eduardo
Fonte: Clinical Chemistry and Laboratory Medicine. Unidades: FORP, FMRP
Assuntos: POLIMORFISMO, METALOPROTEINASES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DEMACQ, Caroline et al. Functional polymorphisms in the promoter of the matrix metalloproteinase-9 (MMP-9) gene are not linked with significant plasma MMP-9 variations in healthy subjects. Clinical Chemistry and Laboratory Medicine, v. 46, n. 1, p. 57-63, 2008Tradução . . Disponível em: https://doi.org/10.1515/cclm.2008.014. Acesso em: 26 out. 2025.
APA
Demacq, C., Vasconcellos, V. B., Marcaccini, A. M., Gerlach, R. F., Silva Júnior, W. A. da, & Tanus-Santos, J. E. (2008). Functional polymorphisms in the promoter of the matrix metalloproteinase-9 (MMP-9) gene are not linked with significant plasma MMP-9 variations in healthy subjects. Clinical Chemistry and Laboratory Medicine, 46( 1), 57-63. doi:10.1515/cclm.2008.014
NLM
Demacq C, Vasconcellos VB, Marcaccini AM, Gerlach RF, Silva Júnior WA da, Tanus-Santos JE. Functional polymorphisms in the promoter of the matrix metalloproteinase-9 (MMP-9) gene are not linked with significant plasma MMP-9 variations in healthy subjects [Internet]. Clinical Chemistry and Laboratory Medicine. 2008 ; 46( 1): 57-63.[citado 2025 out. 26 ] Available from: https://doi.org/10.1515/cclm.2008.014
Vancouver
Demacq C, Vasconcellos VB, Marcaccini AM, Gerlach RF, Silva Júnior WA da, Tanus-Santos JE. Functional polymorphisms in the promoter of the matrix metalloproteinase-9 (MMP-9) gene are not linked with significant plasma MMP-9 variations in healthy subjects [Internet]. Clinical Chemistry and Laboratory Medicine. 2008 ; 46( 1): 57-63.[citado 2025 out. 26 ] Available from: https://doi.org/10.1515/cclm.2008.014
Trabalho de evento-resumo periodico
Up-regulation of ABCG1 mRNA expression by atorvastatin HEPG2 cells (2008)
Genvigir, Fabiana Dalla Vecchia; Rodrigues, Alice Cristina ; Hirata, Mario Hiroyuki ; Willrich, Maria Alice Vieira; Arazi, Simone Sorkin; Hirata, Rosario Dominguez Crespo ; Curi, Rui
Fonte: Clinical Chemistry and Laboratory Medicine. Nome do evento: International Congress of Clinical Chemistry and Laboratory Medicine/IFCC-WorldLab. Unidades: FCF, ICB
Assuntos: EXPRESSÃO GÊNICA, FARMACOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GENVIGIR, Fabiana Dalla Vecchia et al. Up-regulation of ABCG1 mRNA expression by atorvastatin HEPG2 cells. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 26 out. 2025. , 2008
APA
Genvigir, F. D. V., Rodrigues, A. C., Hirata, M. H., Willrich, M. A. V., Arazi, S. S., Hirata, R. D. C., & Curi, R. (2008). Up-regulation of ABCG1 mRNA expression by atorvastatin HEPG2 cells. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Genvigir FDV, Rodrigues AC, Hirata MH, Willrich MAV, Arazi SS, Hirata RDC, Curi R. Up-regulation of ABCG1 mRNA expression by atorvastatin HEPG2 cells. Clinical Chemistry and Laboratory Medicine. 2008 ; 46 ( S1): S563 res W061.[citado 2025 out. 26 ]
Vancouver
Genvigir FDV, Rodrigues AC, Hirata MH, Willrich MAV, Arazi SS, Hirata RDC, Curi R. Up-regulation of ABCG1 mRNA expression by atorvastatin HEPG2 cells. Clinical Chemistry and Laboratory Medicine. 2008 ; 46 ( S1): S563 res W061.[citado 2025 out. 26 ]
Trabalho de evento-resumo periodico
No association of werner syndrome gene Cys1367 Arg polymorphism with risk of gliomas and prognosis in Brazil (2008)
Pinto, G. R.; Yoshioka, F. K. N.; Clara, C. A.; Santos, M. J.; Almeida, J. R. W.; Oliveira, V. M.; Penha, M. R.; Casartelli, Cacilda
Fonte: Clinical Chemistry and Laboratory Medicine. Nome do evento: IFCC - WorldLab. Unidade: FMRP
Assuntos: POLIMORFISMO, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PINTO, G. R. et al. No association of werner syndrome gene Cys1367 Arg polymorphism with risk of gliomas and prognosis in Brazil. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 26 out. 2025. , 2008
APA
Pinto, G. R., Yoshioka, F. K. N., Clara, C. A., Santos, M. J., Almeida, J. R. W., Oliveira, V. M., et al. (2008). No association of werner syndrome gene Cys1367 Arg polymorphism with risk of gliomas and prognosis in Brazil. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Pinto GR, Yoshioka FKN, Clara CA, Santos MJ, Almeida JRW, Oliveira VM, Penha MR, Casartelli C. No association of werner syndrome gene Cys1367 Arg polymorphism with risk of gliomas and prognosis in Brazil. Clinical Chemistry and Laboratory Medicine. 2008 ; 46 S237.[citado 2025 out. 26 ]
Vancouver
Pinto GR, Yoshioka FKN, Clara CA, Santos MJ, Almeida JRW, Oliveira VM, Penha MR, Casartelli C. No association of werner syndrome gene Cys1367 Arg polymorphism with risk of gliomas and prognosis in Brazil. Clinical Chemistry and Laboratory Medicine. 2008 ; 46 S237.[citado 2025 out. 26 ]
Trabalho de evento-resumo periodico
Evaluation of C282Y and H63D mutations in HFE gene and correlation with clinical manifestation of hereditary hemochromatosis (2008)
Oliveira, Taissa Maria Moura; Leão, Gioconda Dias Rodrigues; Fernandes, Andrea Luciana Araújo da Cunha; Vasconcelos, Roberto Chaves de; Carvalho, Márcia Valéria M. de; Mendonça, J. Freire; Hirata, Mario Hiroyuki ; Cavalcanti Júnior, Geraldo Barroso
Fonte: Clinical Chemistry and Laboratory Medicine. Nome do evento: International Congress of Clinical Chemistry and Laboratory Medicine/IFCC-WorldLab. Unidade: FCF
Assuntos: MUTAÇÃO GENÉTICA, HEMOCROMATOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Taissa Maria Moura et al. Evaluation of C282Y and H63D mutations in HFE gene and correlation with clinical manifestation of hereditary hemochromatosis. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 26 out. 2025. , 2008
APA
Oliveira, T. M. M., Leão, G. D. R., Fernandes, A. L. A. da C., Vasconcelos, R. C. de, Carvalho, M. V. M. de, Mendonça, J. F., et al. (2008). Evaluation of C282Y and H63D mutations in HFE gene and correlation with clinical manifestation of hereditary hemochromatosis. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Oliveira TMM, Leão GDR, Fernandes ALA da C, Vasconcelos RC de, Carvalho MVM de, Mendonça JF, Hirata MH, Cavalcanti Júnior GB. Evaluation of C282Y and H63D mutations in HFE gene and correlation with clinical manifestation of hereditary hemochromatosis. Clinical Chemistry and Laboratory Medicine. 2008 ; 46 ( S1): S234 res. M075.[citado 2025 out. 26 ]
Vancouver
Oliveira TMM, Leão GDR, Fernandes ALA da C, Vasconcelos RC de, Carvalho MVM de, Mendonça JF, Hirata MH, Cavalcanti Júnior GB. Evaluation of C282Y and H63D mutations in HFE gene and correlation with clinical manifestation of hereditary hemochromatosis. Clinical Chemistry and Laboratory Medicine. 2008 ; 46 ( S1): S234 res. M075.[citado 2025 out. 26 ]
Trabalho de evento-resumo periodico
Development and evaluation of a biosafe automatized system for treatment, recycling and discarding of clinical microbiology residues (2008)
Largura, Alvaro; Sandrini, Fabiano; Bellato, Gilmar; Andrade, Mauricio Pacheco de; Carvalho, L. G. S.; Marassi, Alisson; Largura, Marco Antonio; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Fonte: Clinical Chemistry and Laboratory Medicine. Nome do evento: International Congress of Clinical Chemistry and Laboratory Medicine/IFCC-WorldLab. Unidade: FCF
Assunto: MICROBIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LARGURA, Alvaro et al. Development and evaluation of a biosafe automatized system for treatment, recycling and discarding of clinical microbiology residues. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 26 out. 2025. , 2008
APA
Largura, A., Sandrini, F., Bellato, G., Andrade, M. P. de, Carvalho, L. G. S., Marassi, A., et al. (2008). Development and evaluation of a biosafe automatized system for treatment, recycling and discarding of clinical microbiology residues. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Largura A, Sandrini F, Bellato G, Andrade MP de, Carvalho LGS, Marassi A, Largura MA, Hirata RDC, Hirata MH. Development and evaluation of a biosafe automatized system for treatment, recycling and discarding of clinical microbiology residues. Clinical Chemistry and Laboratory Medicine. 2008 ; 46 ( S1): S510 res. T197.[citado 2025 out. 26 ]
Vancouver
Largura A, Sandrini F, Bellato G, Andrade MP de, Carvalho LGS, Marassi A, Largura MA, Hirata RDC, Hirata MH. Development and evaluation of a biosafe automatized system for treatment, recycling and discarding of clinical microbiology residues. Clinical Chemistry and Laboratory Medicine. 2008 ; 46 ( S1): S510 res. T197.[citado 2025 out. 26 ]

Unidades USP

ReP

Filtros

Unidades USP

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Nome do evento

Indexado em

Afiliação dos autores externos não normalizada